Publications by authors named "C Piketty"

Claim this Profile
N
Nemolizumab Treatment Normalizes Dysregulated Microbiome in Lesional Prurigo Nodularis.
Ruiwen Zhou, Prasad Chaskar, Matthew T Patrick, Kai Wang, Christophe Piketty

J Invest Dermatol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Letter to the Editor from Dr. Paul et al.
Jonathan I Silverberg, Liliana Ulianov, Christophe Piketty

J Eur Acad Dermatol Venereol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid improvement of itch with nemolizumab in atopic dermatitis and prurigo nodularis phase 3 studies.
Sonja Ständer, Sarina B Elmariah, Shawn G Kwatra, Gil Yosipovitch, Andrew E Pink, Christophe Piketty

J Eur Acad Dermatol Venereol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysis.
Franz J Legat, Shawn G Kwatra, Adam Reich, Serge Boulinguez, Athanasios Tsianakas, Christophe Piketty

J Eur Acad Dermatol Venereol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open-label extension study.
Matthias Augustin, Marie Tauber, Robert Sidbury, Jonathan I Silverberg, Kim A Papp, Christophe Piketty

J Eur Acad Dermatol Venereol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis